Why the study?
Does the ECPKA autoantibody enzyme immunoassay method improve sensitivity and specificity for detecting cancer compared to the conventional antigen determination method?
Population
505 individuals, including 295 patients with cancers of various cell types, 155 normal controls, and 55…
Comparison
ECPKA autoantibody enzyme immunoassay method vs Conventional antigen determination method
Design
Case-control
Authors
Loading...
May support ECPKA autoantibody assay for cancer detection; hypothesis-generating and requires prospective validation before practice change.
Does the ECPKA autoantibody enzyme immunoassay method improve sensitivity and specificity for detecting cancer compared to the conventional antigen determination method?
The ECPKA autoantibody enzyme immunoassay demonstrates higher sensitivity and specificity than conventional antigen methods, suggesting its potential as a universal serum biomarker for various cancers.
Nesterova et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: